These findings suggest QP may alleviate AMD-related pathology through cholesterol metabolism and microbiome modulation.
Frontiers in Immunology · 11 authors, 5 centres
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
These findings suggest QP may alleviate AMD-related pathology through cholesterol metabolism and microbiome modulation.
control diet (CD), high-fat diet (HFD), and HFD treated with Qijudihuang pill (QP). After treatment, cholesterol levels were measured in retina, retinal pigment epithelium (RPE)/choroid, liver, and serum; expression of cholesterol metabolism, oxidative stress, and inflammatory genes was assessed by qRT-PCR; and gut microbiota was analyzed by 16S rRNA sequencing. HFD elevated cholesterol levels, downregulated antioxidant genes (catalase, GPX, SOD1), and upregulated pro-inflammatory mediators (IL-1β, TNF-α) in examined tissues, and these effects were reversed by QP. HFD suppressed bile acid formation enzymes and disrupted bile acid signaling, leading to dysbiosis characterized by increased Bacteroidetes/Firmicutes ratio, which QP partially restored. PICRUSt2 analysis predicted HFD increased pro-inflammatory metabolic pathways (enterobactin, polymixin B, lipopolysaccharide synthesis), reversed by QP. Limitations include the absence of human participants, unknown hepatotoxicity potential of QP, and the need for further investigation into specific molecular mechanisms.